✦ LIBER ✦

Perioperative desensitization therapy decreases acute rejection in sensitized lung transplant recipients

✍ Scribed by James Z. Appel; Barbara O. Burgess; Walter F. Herczyk; Ed Cantu; Matthew G. Hartwig; Scott M. Palmer; R. Duane Davis; Nancy L. Reinsmoen

Book ID: 116530409
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 21 KB
Volume: 65
Category: Article
ISSN: 0198-8859
DOI: 10.1016/j.humimm.2004.07.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody Desensitization Therapy in High

Antibody Desensitization Therapy in Highly Sensitized Lung Transplant Candidates

✍ Snyder, L. D.; Gray, A. L.; Reynolds, J. M.; Arepally, G. M.; Bedoya, A.; Hartwi 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Terminal Complement Inhibition Decreases

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

✍ M. D. Stegall; T. Diwan; S. Raghavaiah; L. D. Cornell; J. Burns; P. G. Dean; F. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

New combination of immunosuppressive the

New combination of immunosuppressive therapy decreases acute rejection in lung transplantation

✍ S.M Bhorade; J Villanueva; A.M Jordan; A Yu; H Kramer; J Leischner; W.T Vigneswa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Interleukin-2-receptor blockade with dac

Interleukin-2-receptor blockade with daclizumab decreases the incidence of acute rejection in pediatric lung transplant recipients

✍ S.C. Sweet; M.T. De La Morena; S.D. Shapiro; E.N. Mendeloff; C.B. Huddleston 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir

352: Simkania negevensis infection and a

352: Simkania negevensis infection and acute rejection in lung transplant recipient

✍ S. Husain; S. Kahane; G. Friedman; K.R. McCurry; J. Pilewski; D.L. Paterson; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 74 KB